Terns Pharmaceuticals, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
2,779,445
Value ($000)
146,532
Weight
0.2%
2021 Q2 - 2026 Q1 (8 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).